Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

被引：371

作者：

Goldhirsch, A

Glick, JH

Gelber, RD

Senn, HJ

机构：

[1] European Inst Oncol, Int Breast Canc Study Grp, I-20141 Milan, Italy

[2] Int Breast Canc Study Grp, Lugano, Switzerland

[3] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA

[4] Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA

[5] Zentrum Tumordiagnost & Pravent, St Gallen, Switzerland

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1998年 / 90卷 / 21期

关键词：

D O I：

10.1093/jnci/90.21.1601

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1601 / 1608

页数：8

共 47 条

[1]

ABE O, 1992, LANCET, V339, P71

[2]

Abe O, 1998, LANCET, V352, P930

[3]

ALBAIN K, 1997, P AN M AM SOC CLIN, V16, pA128

[4]

[Anonymous], LONG TERM TAMOXIFEN

[5] AXILLARY DISSECTION OF LEVEL-I AND LEVEL-II LYMPH-NODES IS IMPORTANT IN BREAST-CANCER CLASSIFICATION [J].

AXELSSON, CK ;

MOURIDSEN, HT ;

ZEDELER, K .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1415-1418

[6]

BLARK GM, 1997, P ASCO, V16, pA129

[7]

BOCCARDO F, 1993, ADJUVANT THERAPY CAN, V7, P181

[8]

BONADONNA G, 1995, JAMA-J AM MED ASSOC, V273, P542

[9] Primary chemotherapy in operable breast cancer: Eight-year experience at the Milan Cancer Institute [J].

Bonadonna, G ;

Valagussa, P ;

Brambilla, C ;

Ferrari, L ;

Moliterni, A ;

Terenziani, M ;

Zambetti, M .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :93-100

[10] Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up [J].

Bontenbal, M ;

Foekens, JA ;

Lamberts, SWJ ;

de Jong, FH ;

van Putten, WLJ ;

Braun, HJ ;

Burghouts, JTM ;

van der Linden, GHM ;

Klijn, JGM .

BRITISH JOURNAL OF CANCER, 1998, 77 (01) :115-122

← 1 2 3 4 5 →